2021
The Association of Fetal Congenital Cardiac Defects and Placental Vascular Malperfusion
Ozcan T, Kikano S, Plummer S, Strainic J, Ravishankar S. The Association of Fetal Congenital Cardiac Defects and Placental Vascular Malperfusion. Pediatric And Developmental Pathology 2021, 24: 187-192. PMID: 33491545, DOI: 10.1177/1093526620986497.Peer-Reviewed Original ResearchMeSH KeywordsAdultCohort StudiesFemaleHeart Defects, CongenitalHumansInfant, NewbornMalePlacenta DiseasesPregnancyRetrospective StudiesConceptsFetal congenital heart defectsFetal vascular malperfusionCongenital heart defectsPlacental perfusion defectsMaternal risk factorsRisk factorsVascular malperfusionCompared to controlsVentricle morphologyGroup 2Group 1Congenital heart defect groupsCongenital heart defect casesPlacental vascular malperfusionCongenital cardiac defectsSingle right ventricleMaternal malperfusionSingleton pregnanciesPlacental disordersCardiac defectsHeart defectsCongenital anomaliesRight ventriclePerfusion defectsGreat vessels
2016
North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome
Emery S, Hasley S, Catov J, Miller R, Moon-Grady A, Baschat A, Johnson A, Lim F, Gagnon A, O'Shaughnessy R, Ozcan T, Luks F, Network N. North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome. American Journal Of Obstetrics And Gynecology 2016, 215: 346.e1-346.e7. PMID: 27131587, DOI: 10.1016/j.ajog.2016.04.024.Peer-Reviewed Original ResearchConceptsTransfusion syndromeLaser therapyExpectant managementStage IPoor outcomePregnancy outcomesPredictors of disease behaviorRecipient maximum vertical pocketRisk of fetal lossDiagnosis of stage ICompare pregnancy outcomesExpectantly managed casesMaximum vertical pocketStage I diseaseProcedure-related complicationsFetal mortality rateOdds of poor outcomeRetrospective observational studyInitial management strategyGestational agePlacenta locationPreterm birthVertical pocketI diseaseFetal loss
2013
Fetal isolated short femur in the second trimester and adverse pregnancy outcomes
Özlü T, Ozcan T. Fetal isolated short femur in the second trimester and adverse pregnancy outcomes. Prenatal Diagnosis 2013, 33: 1063-1069. PMID: 23839963, DOI: 10.1002/pd.4197.Peer-Reviewed Original ResearchConceptsLow birth weightAdverse pregnancy outcomesPreterm birthBirth weightPregnancy outcomesFemur lengthShort femurNeonatal intensive care unit admissionLow birth weight infantsRisk of low birth weightIsolated short femurIntensive care unit admissionIncidence of PEMultiple logistic regressionEligible fetusesSingleton pregnanciesApgar scoreGestational ageTrimester ultrasoundMultiple pregnanciesObstetric scanAbdominal circumferenceChromosomal anomaliesUnit admissionDelivery weight
2010
Mitral valve–tricuspid valve distance as a sonographic marker of trisomy 21
Grace D, Eggers P, Glantz J, Ozcan T. Mitral valve–tricuspid valve distance as a sonographic marker of trisomy 21. Ultrasound In Obstetrics And Gynecology 2010, 35: 172-177. PMID: 20069681, DOI: 10.1002/uog.7538.Peer-Reviewed Original ResearchConceptsMitral valve-tricuspid valve distanceMarkers of trisomyGestational ageSonographic markersTrisomy 21Cardiac defectsLinear regression analysisGestational age-specific percentilesSecond-trimester sonographic markersEffect of gestational ageRetrospective case-control studyCases of trisomyValve distanceMultiple linear regression analysisRegression analysisCase-control studyAge-specific percentilesWeeks gestationControl fetusesSecond-trimesterTricuspid valveVentricular septumFalse-positive rateTrisomyFetuses
2006
The effect of anticoagulation on antenatal ultrasound findings in pregnant women with thrombophilia
Magriples U, Ozcan T, Karne A, Copel JA. The effect of anticoagulation on antenatal ultrasound findings in pregnant women with thrombophilia. The Journal Of Maternal-Fetal & Neonatal Medicine 2006, 19: 27-30. PMID: 16492587, DOI: 10.1080/14767050500463558.Peer-Reviewed Original ResearchConceptsAbnormal Doppler resultsUntreated pregnanciesPregnant womenGrowth restrictionDoppler resultsFeto-placental blood flowClose antenatal surveillanceRisk of oligohydramniosUse of anticoagulationCohort of patientsEffect of anticoagulationAntenatal ultrasound findingsPresence of abnormalitiesHeparin altersAntenatal surveillanceGenetic thrombophiliaPregnancy complicationsRetrospective studyUltrasound findingsAbnormal ultrasoundBlood flowOverall outcomeThrombophiliaPregnancyPatients
1995
Ritodrine Tocolysis and Neonatal Intraventricular-Periventricular Hemorrhage
Özcan T, Turan C, Ekici E, Gökmen O, Doğan M, Kaleli B, Uludağ H, Karayalçın R. Ritodrine Tocolysis and Neonatal Intraventricular-Periventricular Hemorrhage. Gynecologic And Obstetric Investigation 1995, 39: 60-62. PMID: 7890256, DOI: 10.1159/000292378.Peer-Reviewed Original ResearchConceptsGroup ACombination therapyBetamimetic drugsBetamimetic therapyNeonatal IVHTocolysis failureTocolytic therapyPreterm deliveryNeonatal hemorrhageNo-treatment groupPreterm birthUltrasonography resultsNo significant differenceGroup BRitodrineStudy groupTocolysisGroup CPatientsTherapySignificant differenceMagnesium sulfatePretermIVHIncidence